ABACAVIR + LAMIVUDINE
abacavir 600 mg + lamivudine 300 mg tablet, 30
ABACAVIR + LAMIVUDINE (10357D)
10357D
Manner of administration:Oral
Restriction 4527
Indication: HIV infection
Treatment phase: Initial
Restriction 4528
Indication: HIV infection
Treatment phase: Continuing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $81.10 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Abacavir/Lamivudine Viatris | |||||
